(Q39816354)

14 September 2017

Influence of plasma exchange pheresis on plasma elimination of ceftriaxone (English)

1 reference

14 September 2017

Bakken JS

1

1 reference

14 September 2017

Cavalieri SJ

series ordinal

2

1 reference

14 September 2017

Gangeness D

series ordinal

3

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 June 1990

1 reference

Antimicrobial Agents and Chemotherapy

14 September 2017

1 reference

14 September 2017

34

1 reference

14 September 2017

6

1 reference

14 September 2017

1276-1277

1 reference

Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration

14 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171801

Kinetics of ceftazidime during plasmapheresis

22 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171801

Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics.

15 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171801

Ceftriaxone: renal and biliary excretion and effect on the colon microflora

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2393290

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2393290

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.34.6.1276

1 reference

14 September 2017

1 reference

14 September 2017

PubMed publication ID

2393290

1 reference